Cargando…
A Perspective on the Development of TGF-β Inhibitors for Cancer Treatment
Transforming growth factor (TGF)-β is a secreted multifunctional cytokine that signals via plasma membrane TGF-β type I and type II receptors and intercellular SMAD transcriptional effectors. Aberrant inter- and intracellular TGF-β signaling can contribute to cancer progression. In normal cells and...
Autores principales: | Huynh, Linh Khanh, Hipolito, Christopher John, ten Dijke, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921009/ https://www.ncbi.nlm.nih.gov/pubmed/31744193 http://dx.doi.org/10.3390/biom9110743 |
Ejemplares similares
-
TGFβ Signaling and Cardiovascular Diseases
por: Pardali, Evangelia, et al.
Publicado: (2012) -
TGF-β in progression of liver disease
por: Dooley, Steven, et al.
Publicado: (2011) -
A current perspective on applications of macrocyclic‐peptide‐based high‐affinity ligands
por: Leenheer, Daniël, et al.
Publicado: (2016) -
Targeting TGFβ signal transduction for cancer therapy
por: Liu, Sijia, et al.
Publicado: (2021) -
TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis
por: Hao, Yang, et al.
Publicado: (2019)